Navigation Links
A Discovery That may Lessen a Health Disparity

Mayo Clinic Cancer Center scientists, in collaboration with Chinese researchers, have isolated// an enzyme that could be used to predict survival and recurrence rates for nasopharyngeal cancer -- a common cancer affecting people from Southeast Asia. Results of the study were presented today by lead author Jin-Ping Lai, M.D., Ph.D., at the American Association for Cancer Research annual meeting.

Nasopharyngeal cancer disproportionately affects people living in southern China and surrounding areas, as well as recent Southeast Asian immigrants to the United States, says the American Cancer Society. It also is common in Alaska Natives and is 50 percent more likely to occur in blacks than in whites.

SULF2, a recently identified heparin-degrading endosulfatase, appears to be significantly overexpressed in nasopharyngeal cancers, providing hope of the eventual ability to predict recurrence and subsequent prognosis after radiation therapy, the standard treatment for nasopharyngeal cancer.

The researchers examined tumor tissue from 55 patients with squamous cell carcinoma of the nasopharynx, otherwise known as nasopharyngeal cancer. All patients had been treated by radiation therapy and follow-up was conducted for 10 years. The investigators found that rates of early recurrence (within five years) were significantly higher for individuals with high levels of SULF2 in the tumor (expressed in more than 10 percent of cancer cells). These same individuals were much more likely to die within 10 years.

“Learning more about the way a specific type of cancer develops, and what proteins it produces as it grows, helps us find better ways to treat that cancer,” said Dr. Lai, who is a cancer researcher at Mayo Clinic with background as an otolaryngologist. “With nasopharyngeal cancer, we think this new enzyme may help solve the puzzle.”

Locating the enzyme also allowed Dr. Lai and his colleagues to make the antibody for SULF2,
'"/>




Page: 1 2

Related medicine news :

1. Discovery of bone gene
2. New Discovery May Help Treat Infertility
3. New Discovery to Increase Survival of Breast cancer Patients
4. Discovery of World’s smallest laser
5. Discovery of a built-in fat sensor
6. OHSU Researchers Announce New Discovery
7. Discovery Of New Molecule Could Solve Cancer Spread Mystery
8. Discovery Of Human Skeletons Could Unfold Facts About By-Gone Ages
9. New Discovery Shows That Brain Could repair Itself After Stroke
10. New Sleep Gene Discovery Wakes Up Scientists
11. Discovery of Elevated Amyloid Peptide levels could lead to Alzheimer’s Preventio
Post Your Comments:
(Date:12/2/2008)... Randomized Comparator Study to Evaluate Efficacy... , , WOODCLIFF LAKE, N.J., Dec. 2 /PRNewswi...nounced that it plans to initiate the first clinic...citabine for injection) compared to Vidaza(R) (aza...ntermediate-2 or high-risk myelodysplastic syndrom...
(Date:12/2/2008)... DENVER, Dec. 2 Barotz Dental is ...fering LANAP(TM) (Laser Assisted New Attachment,P...rotocol that is patented,and FDA approved for new..., LANAP removes diseased tissue, without rem... tissue around teeth, minimizes pain and discomfor...
(Date:12/2/2008)... DENVER, Dec. 2 Global ...ompany") (OTC Bulletin Board: GLOB), an internatio...any, today announced that its,European subsidiary...on,Software, marketed as "Hemo Serveur" in France..."AP-HP") hospitals, representing 23,000 patient be...
(Date:12/2/2008)... FISHERS, Ind., Dec. 2 A number o... rise in childhood obesity, the health risks in,o...al value of cereals and,other foods kids consume....,-- offers all natural, freeze-dried real fruit pr...ids, but also provide most, if not all, of the dai...
Breaking Medicine News(10 mins):Health News:Eisai Will Initiate First Head-to-Head Study Comparing Dacogen(R) (decitabine for injection) and Vidaza(R) (azacitidine) in Patients with Myelodysplastic Syndromes 2Health News:Eisai Will Initiate First Head-to-Head Study Comparing Dacogen(R) (decitabine for injection) and Vidaza(R) (azacitidine) in Patients with Myelodysplastic Syndromes 3Health News:Barotz Dental Now Offering Laser Gum Therapy 2Health News:Global Med Technologies(R)' European Subsidiary to Provide Strategic Blood Transfusion Software for 21 Paris Hospitals 2Health News:Global Med Technologies(R)' European Subsidiary to Provide Strategic Blood Transfusion Software for 21 Paris Hospitals 3Health News:Global Med Technologies(R)' European Subsidiary to Provide Strategic Blood Transfusion Software for 21 Paris Hospitals 4Health News:Moms Find Fun, Healthy Snacks That Help Fight Childhood Obesity 2Health News:Moms Find Fun, Healthy Snacks That Help Fight Childhood Obesity 3
...002, the number of drug users who completed the tr... of an increase in the number of people enrolling/...e more likely to drop out of treatment if they had...tem than if they had entered by other routes. This...
...ny Abbott yesterday accused the commonwealth of ba...ver how the public money was spent.// He attacke...d beggars" and blame-shifters who should be able t...he "river of gold" of GST receipts. State health...
...st producer of milk in the world but paradoxically...ren being the worst deprived, parliament was infor...ilk in India is 229 gm per day as against 887.7 gm...in Sweden, France (777.5) and Germany (741.52). I...
...utical Union (IPU) has insisted that the 'morning ...ounter to patients without a doctor's prescription...vonelle, has been licensed for use in Ireland sinc...must have a doctor's prescription. The pharmacists...
Other Medicine News:Health News:Health Minister Slams State Health Governments 2Health News:The IPU Want Morning After Pills To Be Made Available Over The Counter 2
(Date:11/26/2008)...e-USNewswire/ -- Children whose eyes are misaligne... risk of developing mental illness by early adulth... published this month in Pediatrics , the official... , The retrospective study examined the medi...igned eyes) and compared them with records of chil...
(Date:11/26/2008)... , FRANKLIN, Mass., Nov. 26 /PRNewswire-FirstCa...) announced today that it has received full approv...) for its U.S. pivotal trial to study the effectiv...associated therapy in the prevention of Contrast-I...approved PLC,s request to expand their investigati...
(Date:11/25/2008)...-USNewswire/ -- Kleinert Kutz and University of L...hand transplant on Messina, New York resident, Jan...Hand Care Center on Monday, November 24. The inno...ed shortly after 9 p.m. in a record nine hours. ,...prnh/20081125/DC48555-a ) , (Photo: http://ww...
(Date:11/25/2008)... Proteolix, Inc., a,leader in the...hat target,protein degradation pathways in cancer...ta from two ongoing Phase 2 clinical trials of car... the upcoming 50th Annual Meeting of the,American...first in a new class,of specific proteasome inhib...
Breaking Medicine Technology:Eye Divergence in Children Triples Risk of Mental Illness 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 3PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 4Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 2Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 3Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 2Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 3BioMarin Re Acquires Rights to Kuvan in Canada From Merck Serono 8454 1BioMarin Re Acquires Rights to Kuvan in Canada From Merck Serono 8454 2BioMarin Re Acquires Rights to Kuvan in Canada From Merck Serono 8454 3BioMarin Re Acquires Rights to Kuvan in Canada From Merck Serono 8454 4Dr Peter B Corr Joins Team at Celtic Therapeutics as General Partner 8450 1Dr Peter B Corr Joins Team at Celtic Therapeutics as General Partner 8450 2Dr Peter B Corr Joins Team at Celtic Therapeutics as General Partner 8450 3Dr Peter B Corr Joins Team at Celtic Therapeutics as General Partner 8450 4Laser Therapy Gives Smokers Hope for Successful New Years Resolution 2265 1Laser Therapy Gives Smokers Hope for Successful New Years Resolution 2265 2WellGen Inc Names Nancy E Rawson Ph D Chief Scientific Officer 2261 1WellGen Inc Names Nancy E Rawson Ph D Chief Scientific Officer 2261 2WellGen Inc Names Nancy E Rawson Ph D Chief Scientific Officer 2261 3
... SEATTLE, June 04, 2007 /PRNewswire-FirstCall/ --...indings were presented from a,Phase 1b clinical tr...eukemia (B-CLL) at the American Society of Clinica...ncluded intravenous,administration of higher doses...ound that atacicept was well-tolerated and biologi...
... HAWTHORNE, N.Y.--(BUSINESS WIRE)--Jun 4, 2007 - A...nnounced that the,Company presented a "meta-analys... Fampridine-SR in multiple sclerosis during a,post... and Research,in MS (ACTRIMS) Meeting in Washingto...lidation of Consistent Improvement in Walking,Spee...
Other Medicine Technology:ZymoGenetics Reports Results From Atacicept Phase 1b Clinical Trial,in B-Cell Chronic Lymphocytic Leukemia 2ZymoGenetics Reports Results From Atacicept Phase 1b Clinical Trial,in B-Cell Chronic Lymphocytic Leukemia 3Acorda Therapeutics Presents Fampridine-SR Data at ACTRIMS Meeting 2Acorda Therapeutics Presents Fampridine-SR Data at ACTRIMS Meeting 3Acorda Therapeutics Presents Fampridine-SR Data at ACTRIMS Meeting 4
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
Medicine Products: